Mhedzisiro yekurapa kenza pamoyo

Pane zvimwe zvinokanganisa chemotherapy & radiotherapy pamoyo pedu pakurapa gomarara. Batanidza ne + 91 96 1588 1588 kuziva zvakawanda.

Share This Post

Pane zvimwe zvinokonzeresa zvine chekuita nemoyo kana marapirwo ekurapa cancer akaiswa senge chemotherapy neradiotherapy. Nzira dzekurapa idzi dzinogona kukuvadza moyo, uye mhedzisiro yadzo inosanganisira BP, kurova kwemwoyo kusiri kwemazuva ese, uye kutadza kushanda kwemoyo. Kana zvinhu zvakadaro zvikaitika, chiremba angasarudza kunonoka, kugadzirisa, kana kutombomisa kurapa zvachose. Zvisinei, mamwe emigumisiro yekurapa inogona kuitika mushure menguva yakareba uye inoramba isingazivikanwi kwenguva pfupi.

Zvichangobva kuitika mu immunotherapy kurapwa kwegomarara zvakaratidzwawo kuti zvinosanganiswa nengozi yemigumisiro yemwoyo nemigumisiro.

Nekudaro, kutsvagisa kwakawanda kunodiwawo kubatsira kuzivisa sarudzo dzekiriniki nezve marapirwo egomarara uye mhedzisiro yemoyo. Ndichiri kurapa varwere vegomarara, vanachiremba vanofanirwa kuraira murwere nezve dzimwe nyaya dzehutano dzinogona kunge dzakabatanidzwa nezvinetso zvemoyo seshuga necholesterol. Kutsvakurudza kwakawanda kuri munzira maererano neizvi.

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Lutetium Lu 177 dotatate inotenderwa neUSFDA kune vana vane makore gumi nemaviri zvichikwira neGEP-NETS.
kenza

Lutetium Lu 177 dotatate inotenderwa neUSFDA kune vana vane makore gumi nemaviri zvichikwira neGEP-NETS.

Lutetium Lu 177 dotatate, kurapwa kwepasi, ichangobva kugamuchira mvumo kubva kuUS Food and Drug Administration (FDA) yevarwere vevana, zvichiratidza chiitiko chakakosha muvana oncology. Mvumo iyi inomiririra chiedza chetariro kuvana vari kurwisana neuroendocrine tumors (NETs), isingawanzowanikwi asi inonetsa yegomarara iro rinowanzoratidza kuti rinoshingirira pakurapa kwakajairika.

Nogapendekin alfa inbakicept-pmln inotenderwa neUSFDA yeBCG-isingapindure isiri-muscle invasive cancer cancer.
Chirwere chechirwere

Nogapendekin alfa inbakicept-pmln inotenderwa neUSFDA yeBCG-isingapindure isiri-muscle invasive cancer cancer.

"Nogapendekin Alfa Inbakicept-PMLN, chinyorwa che immunotherapy, chinoratidza vimbiso mukurapa gomarara redundira kana yasanganiswa neBCG therapy. Iyi nzira yekuvandudza yakanangana nemakaki egomarara uku ichisimudzira mhinduro ye immune system, ichiwedzera kushanda kwemishonga yechivanhu seBCG. Miedzo yemakiriniki inoratidza zvinokurudzira, zvichiratidza zvakavandudzwa mhedzisiro yemurwere uye kufambira mberi kunogona kuitika mukurapa kenza yedundira. Kuwirirana pakati peNogapendekin Alfa Inbakicept-PMLN neBCG kunozivisa nguva itsva mukurapa gomarara redundira.

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa